Clinical study for the correlation between EMT typing of circulating tumor cells (CTCs) and recurrence and prognosis of gynecological malignant tumor patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023424

Enrollment

Unknown

Registered

2019-05-27

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecologic malignant tumor

Interventions

grouping by EMT typing of circulating tumor cells (CTCs):no intervention

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1)Histologically confirmed epithelial ovarian cervical cancer and endometrial cancer; 2)Eastern Cooperative Oncology Group (ECOG) status 0-1; 3)Patients aged above 18; 4) Surgery can be performed after clinical evaluation; 5) Preoperative imaging evaluation was completed, including ultrasound, MRI, CT and/or pet-ct; 6)Signing informed consent.

Exclusion criteria

Exclusion criteria: 1) Participating in other clinical trials; 2) Combined with other malignant tumors; 3) Patients with extensive metastatic lesions; 4) Heart, lung, liver or kidney obvious abnormalities, coagulation dysfunction and other operation contraindication.

Design outcomes

Primary

Measure	Time frame
1, 3 years relapse/ metastasize Rate; survival rate; overall survival rate;	—

Countries

China

Contacts

Public ContactLiu Shujuan

Department of Obstetrics and Gynecology, the first Affiliated Hospital of the Fourth Military Medical University

hanliu@fmmu.edu.cn+86 17791800036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026